Pediatrix Medical Group MD Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Free cash flow margin | 12.3%+2.5pp | 13.2%+4.0pp | 14.2%+8.5pp | 11.7%+6.7pp | 9.8%+5.8pp | |
| Efficiency | ||||||
| Asset turnover | 1×0.0× | 0.9×-0.1× | 0.9×0.0× | 0.9×0.0× | 0.9×+0.1× | |
| Liquidity | ||||||
| Current ratio | 1.3×-0.5× | 1.7×+0.2× | 1.8×+0.4× | 1.8×+0.4× | 1.8×+0.1× | |
| Quick ratio | 1.3×-0.5× | 1.7×+0.2× | 1.8×+0.4× | 1.8×+0.4× | 1.8×+0.1× | |
| Cash ratio | 0.5×+0.1× | 0.8×+0.3× | 0.9×+0.6× | 0.7×+0.6× | 0.4×+0.3× | |
| Leverage | ||||||
| Debt-to-equity | 0.7×-0.1× | 0.7×-0.1× | 0.7×+0.6× | 0.8×+0.7× | 0.8×+0.7× | |
| Debt-to-assets | 0.3×0.0× | 0.3×0.0× | 0.3×+0.3× | 0.3×+0.3× | 0.3×+0.3× | |
| Per Share | ||||||
| Book value per share | $10.58+14.5% | $10.14+10.4% | $10.40+20.0% | $9.75+15.0% | $9.24-10.2% | |
| Valuation | ||||||
| Market capitalization | $1.78B+42.9% | $1.84B+63.0% | $1.46B+51.0% | $1.16B+82.6% | $1.24B+49.6% | |
| Enterprise value | $2.2B+22.3% | $2.1B+34.2% | $1.76B+87.7% | $1.58B+126% | $1.8B+98.1% | |
| Price / sales | 0.9×+0.3× | 1×+0.4× | 0.8×+0.3× | 0.6×+0.3× | 0.6×+0.2× | |
| Price / book | 2×+0.4× | 2.1×+0.6× | 1.6×+0.3× | 1.4×+0.5× | 1.6×+0.6× | |
| EV / sales | 1.1×+0.2× | 1.1×+0.3× | 0.9×+0.4× | 0.8×+0.5× | 0.9×+0.5× | |
| Free cash flow yield | 13.4%-2.3pp | 13.8%-2.6pp | 18.7%+6.8pp | 19.6%+3.8pp | 15.6%+5.8pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Pediatrix Medical Group's ratios come from?
- Every ratio is computed from Pediatrix Medical Group's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.